Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: Experience from a single center.

ABSTRACT:

Aims

To investigate the predicted factors influencing the outcomes in acute ischemic stroke (AIS) patients who received tirofiban after endovascular treatment (EVT) and the optimal administration of tirofiban.

Methods

In this retrospective study, AIS patients who received EVT followed by tirofiban between January 2017 and October 2021 were enrolled. The dose and duration of tirofiban were adjusted by trained clinicians according to the patient's clinical status. A reduction of at least four points on the National Institutes of Health Stroke Scale (NIHSS) after tirofiban compared with that before tirofiban was defined as an effective response. A modified ranking scale (mRS) of 0-2 was defined as a favorable outcome at a 90-day follow-up.

Results

A total of 260 consecut

SUBMITTER: Wang Y 

PROVIDER: S-EPMC9928549 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature